Translational Research Pilot Awards T3/T4: Clinical Practice and Population Health
Scope of Proposals
This funding opportunity is for projects in the T3 or T4 stage of translational research (For further information on the T stages of research, see Blumberg et al. Nat Med 18: 35-41). T3/4 phases of translational research address gaps in knowledge for interventions with proven efficacy and safety in optimal settings.
T3 is described as research that yields knowledge about how interventions work in real-world settings. Pilot T3 studies might explore whether interventions or strategies can be applied in general practice.
T4 is described as research that applies knowledge to improve population health. Pilot T4 projects might examine the impact of interventions or strategies on the prevalence of disease in a population or on the health of a population.
Examples of projects that might fit this opportunity would include
Maximum Award Requests:
Pilot awards may request up to $25,000 direct costs for one year. No indirect support will be provided.
|April 7, 2017||Applications Due by 11:59 p.m.|
|May 3, 2017||Application Review Competed|
|July 2017||Funding Begins*|
*Exact date may vary. Funds stem from an institutional award made by the National Center for Advancing Translational Sciences (NCATS). Federal policy requires that the project may not commence until a representative from NCATS has administratively approved the pilot projects selected by CTSI. The NCATS approval process cannot commence until required approvals (IRB, IACUC, hSCRO, IBC, CORID, etc.) are obtained. NCATS approval will likely take at least four weeks.